HRT Financial’s ChemoCentryx, Inc. CCXI Stock Holding History

HRT Financial’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-192,459	Closed	-$9.94M	–	3821
2022 Q3	$9.94M	Buy	+192,459	New	+$7.95M	0.11%	140
2022 Q1	–	Sell	-106,583	Closed	-$3.88M	–	4160
2021 Q4	$3.88M	Buy	+106,583	New	+$3.74M	0.02%	374
2021 Q2	–	Sell	-5,293	Closed	-$271K	–	3765
2021 Q1	$271K	Buy	+5,293	New	+$318K	﹤0.01%	2159

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

HRT Financial's CCXI Position: Q4 2022 in Review

HRT Financial sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 192,459 shares — an estimated $9.94M sold.

HRT Financial first reported a position in CCXI in Q1 2021 and held it in 3 quarters. The position peaked at $9.94M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

HRT Financial reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
HRT Financial sold 192,459 ChemoCentryx, Inc. shares in Q4 2022, an estimated $9.94M.
HRT Financial first reported a position in ChemoCentryx, Inc. in Q1 2021 and held it in 3 quarters.
HRT Financial's ChemoCentryx, Inc. position peaked at $9.94M in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on HRT Financial's 13F filing for Q4 2022, filed 10 Feb 2023.